Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The natural history of primary progressive MS in British Columbia, Canada.
MHC transmission: insights into gender bias in MS susceptibility.
Demyelination of the hippocampus is prominent in the cuprizone model.
HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.
Neuroprotection mediated through estrogen receptor-alpha in astrocytes.
IL-17 and Th17 Cells.
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
Nancy Davis Foundation Annual MS Expo and Health Forum
Multiple sclerosis in Hispanics: a study of clinical disease expression.
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
The relevance of animal models in multiple sclerosis research.
IL-2Rβγ-signaling contributes to regulatory T cell maintenance and stability in daclizumab HYP-treated RRMS patients
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort.
Environmental, modifiable risk factors for multiple sclerosis
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis.
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Teriflunomide modest help but safe for MS
Keystone Symposium: Neuroepigenetics
28th Congress of European Committee for Treatment and Research in Multiple Sclerosis Congress

Pages